Published in Circ J on August 01, 2007
The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev (2012) 2.01
Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study). PLoS Med (2010) 1.68
Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein. J Biomed Sci (2011) 0.78
Lower vital capacity is associated with diabetes but not with metabolic syndrome in nonobese Japanese men. Diabetes Care (2009) 2.02
Incidence of type 2 diabetes in individuals with central obesity in a rural Japanese population: the Tanno and Sobetssu study: Response to Ohnishi et al. Diabetes Care (2006) 1.42
The metabolic syndrome (emperor) wears no clothes: response to Kahn. Diabetes Care (2006) 0.87
Japanese criteria of metabolic syndrome. Circ J (2006) 0.83
Obesity-related risk factors of cardiovascular disease. Circ J (2009) 0.82
New criteria for 'obesity disease' in Japan. Circ J (2006) 0.82
Cut points of waist circumference: Response to Sone and colleagues. Diabetes Care (2006) 0.82
LDL cholesterol is associated with blood pressure in Japanese women. Diabetes Care (2009) 0.78
Bilirubin is negatively associated with A1C independently of fasting plasma glucose, age, obesity, inflammation, hemoglobin, and iron in apparently healthy Japanese men and women. Diabetes Care (2010) 0.78
Minimum waist and visceral fat values for identifying Japanese Americans at risk for the metabolic syndrome: response to Hayashi et al. Diabetes Care (2007) 0.78
Lower vital capacity is associated with diabetes but not with metabolic syndrome in nonobese Japanese men: Response to Nakajima and Saito. Diabetes Care (2009) 0.78
Letter by Oda regarding article "relationships between indices of obesity and its cardiovascular comorbidities in a Chinese population". Circ J (2008) 0.77
Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo study: response to Kramer et al. Diabetes Care (2009) 0.77
Criteria for diagnosing the metabolic syndrome. Am J Clin Nutr (2006) 0.76
Metabolic syndrome and CRP. Circ J (2007) 0.76
Definition of metabolic syndrome. Intern Med (2006) 0.75
Letter by Oda et al regarding article, "Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men". Circ J (2008) 0.75
Multiple metabolic risk factors per se are more important than anthropometric cutoff points to predict morbid effects of obesity. Intern Med (2010) 0.75
Metabolic syndrome and medical expenditure in Japan. Circ J (2007) 0.75
C-reactive protein as an optional component of metabolic syndrome. Metabolism (2006) 0.75
Definition of metabolic syndrome. Stroke (2007) 0.75
C-reactive protein cutoff point as a risk factor for coronary spasm. Circ J (2007) 0.75
C-Reactive protein cutoff-point of 0.65 mg/L may be appropriate not only as a component of metabolic syndrome but also as a risk predictor of cardiovascular disease. Circ J (2007) 0.75
Impaired glucose tolerance, impaired fasting glucose and cardiovascular risk. Circ J (2007) 0.75
Relationship between renal dysfunction and severity of coronary artery disease in Japanese patients. Circ J (2010) 0.75
Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students. Circ J (2010) 0.75
High-sensitivity C-reactive protein (CRP) may be superior to anthropometric parameters as a marker of metabolic consequences due to obesity. Comment on the article by Komatsu et al. Endocr J (2007) 0.75
Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome? Comment on the article by Yasuda et al. Endocr J (2007) 0.75
n-3 Fatty acids and the endocannabinoid system. Am J Clin Nutr (2007) 0.75
Letter by Oda et al regarding article, "clinical significance of high-molecular weight form of adiponection in male patients with coronary artery disease". Circ J (2008) 0.75
High-sensitivity C-reactive protein and metabolic syndrome (insulin resistance syndrome), including nonalcoholic steatohepatitis. J Gastroenterol (2008) 0.75
Optimal cutoff points of waist circumference for the criteria of abdominal obesity: comparison with the criteria of the International Diabetes Federation. Circ J (2010) 0.75
It is time to reconsider position of metabolic syndrome in preventive medicine. Intern Med (2012) 0.75
Rise in international normalized ratio after a catastrophic earthquake in patients treated with warfarin. Int J Cardiol (2011) 0.75
Weight reduction may be beneficial for Japanese men with cardiometabolic risk factors even if they are not abdominally obese. Diabetes Care (2010) 0.75